InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
3.000
+0.020 (0.67%)
Dec 20, 2024, 4:00 PM EST - Market closed
InspireMD Market Cap
InspireMD has a market cap or net worth of $78.25 million as of December 20, 2024. Its market cap has increased by 45.18% in one year.
Market Cap
78.25M
Enterprise Value
39.08M
1-Year Change
45.18%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $78.25M, an increase of 42.53%. That is a compound annual growth rate of 2.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 78.30M | 29.21% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ikena Oncology | 76.73M |
Unicycive Therapeutics | 76.28M |
I-Mab | 75.82M |
Rani Therapeutics Holdings | 75.23M |
Generation Bio Co. | 74.71M |
Genelux | 74.35M |
Ovid Therapeutics | 73.69M |
Aerovate Therapeutics | 73.34M |